Ropeginterferon for Treatment Free Remission
NCT07105319
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
65
Enrollment
OTHER
Sponsor class
Conditions
CML (Chronic Myelogenous Leukemia)
Interventions
DRUG:
Ropeginterferon
Sponsor
Dong-Wook Kim